Piramal Enterprises’ arm enters into agreement with G&W Laboratories

20 Jun 2020 Evaluate

Piramal Enterprises’ pharma solutions business, a leading Contract Development and Manufacturing Organization (CDMO), has entered into an agreement with G&W Laboratories Inc. to acquire its solid oral dosage drug product manufacturing facility located in Sellersville, Pennsylvania.

According to the terms of the agreement, the company, through one of its Affiliates, would acquire at closing a 100% stake in G&W PA Laboratories LLC (G&W PA) in an all-cash deal for a total consideration of $17.5 million. This acquisition broadens the offering of Piramal Pharma Solutions (PPS) by adding solid oral dosage form capabilities (tablets and capsules) in North America.

Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.

Piramal Ent - Amalga Share Price

1124.60 0.00 (0.00%)
22-Sep-2025 16:59 View Price Chart
Peers
Company Name CMP
Bajaj Finance 927.85
Shriram Finance 1003.45
Aditya Birla Capital 347.85
Chola Invest & Fin. 1642.60
Tata Capital 352.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×